Newrise Healthcare Profile
Key Indicators
- Authorised Capital ₹ 80.00 Cr
- Paid Up Capital ₹ 70.40 Cr
- Company Age 22 Year, 10 Months
- Last Filing with ROC 31 Mar 2017
- Satisfied Charges ₹ 101.00 Cr
- Revenue Growth 164.15%
- Profit Growth -4.88%
- Ebitda -1.66%
- Net Worth 38.26%
- Total Assets 1.17%
About Newrise Healthcare
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110DL2002PTC114987
- Company No.
114987
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 2002
- Date of AGM
05 Aug 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Newrise Healthcare?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kesavan Venugopalan  | CFO | 26-Jun-2017 | Current |
| Seshiah Sridhar | Company Secretary | 26-Jun-2017 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Viren Shetty | Director | 21-Apr-2017 | Current |
| Arun Seth | Director | 22-May-2017 | Current |
| Manohar Chatlani | Director | 22-May-2017 | Current |
| Subramanya Nagappa | Director | 22-May-2017 | Current |
| Ashutosh Raghuvanshi | Director | 21-Apr-2017 | Current |
Financial Performance of Newrise Healthcare.
Newrise Healthcare Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 164.15% increase. The company also saw a slight decrease in profitability, with a 4.88% decrease in profit. The company's net worth Soared by an impressive increase of 38.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Newrise Healthcare?
In 2017, Newrise Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Usha Breco LimitedArun Seth is a mutual person
Soch Apparels Private LimitedManohar Chatlani is a mutual person
Qs-Era India Private LimitedSubramanya Nagappa is a mutual person
_PRIVATE_LIMITED.webp)
Pamp Technologies (India) Private LimitedArun Seth is a mutual person
Md Retail India Private LimitedManohar Chatlani is a mutual person
Kent R O Systems LimitedArun Seth is a mutual person
Charges (Loans)
₹0
₹101.00 Cr
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 101.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 May 2011 | Bank Of Baroda | ₹101.00 Cr | Satisfied |
How Many Employees Work at Newrise Healthcare?
Unlock and access historical data on people associated with Newrise Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Newrise Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Newrise Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
